Northern Trust’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.71M Buy
934,495
+54,658
+6% +$392K ﹤0.01% 2305
2025
Q1
$5.27M Sell
879,837
-32,876
-4% -$197K ﹤0.01% 2384
2024
Q4
$7.12M Buy
912,713
+65,415
+8% +$510K ﹤0.01% 2317
2024
Q3
$9.15M Buy
847,298
+127,846
+18% +$1.38M ﹤0.01% 2117
2024
Q2
$6.06M Buy
719,452
+4,358
+0.6% +$36.7K ﹤0.01% 2282
2024
Q1
$4.81M Buy
715,094
+1,507
+0.2% +$10.1K ﹤0.01% 2479
2023
Q4
$4.2M Buy
713,587
+725
+0.1% +$4.26K ﹤0.01% 2606
2023
Q3
$6.95M Buy
712,862
+98,532
+16% +$961K ﹤0.01% 2237
2023
Q2
$7.27M Buy
614,330
+63,402
+12% +$751K ﹤0.01% 2270
2023
Q1
$5.94M Buy
550,928
+8,193
+2% +$88.4K ﹤0.01% 2347
2022
Q4
$6.27M Buy
542,735
+7,132
+1% +$82.4K ﹤0.01% 2338
2022
Q3
$7.99M Buy
535,603
+179,678
+50% +$2.68M ﹤0.01% 2153
2022
Q2
$3.21M Buy
355,925
+61,741
+21% +$557K ﹤0.01% 2797
2022
Q1
$2.2M Sell
294,184
-15,064
-5% -$113K ﹤0.01% 3048
2021
Q4
$2.65M Sell
309,248
-21,202
-6% -$182K ﹤0.01% 3077
2021
Q3
$2.78M Sell
330,450
-11,544
-3% -$97.1K ﹤0.01% 3102
2021
Q2
$2.77M Buy
341,994
+281,768
+468% +$2.29M ﹤0.01% 3198
2021
Q1
$529K Buy
60,226
+6,746
+13% +$59.3K ﹤0.01% 3803
2020
Q4
$601K Buy
53,480
+46,552
+672% +$523K ﹤0.01% 3674
2020
Q3
$65K Buy
6,928
+1,537
+29% +$14.4K ﹤0.01% 4060
2020
Q2
$10K Hold
5,391
﹤0.01% 4214
2020
Q1
$9K Buy
5,391
+2,461
+84% +$4.11K ﹤0.01% 4157
2019
Q4
$8K Hold
2,930
﹤0.01% 4206
2019
Q3
$17K Sell
2,930
-40,893
-93% -$237K ﹤0.01% 4166
2019
Q2
$459K Sell
43,823
-3,187
-7% -$33.4K ﹤0.01% 3578
2019
Q1
$826K Buy
47,010
+2,350
+5% +$41.3K ﹤0.01% 3425
2018
Q4
$786K Buy
44,660
+33,836
+313% +$596K ﹤0.01% 3437
2018
Q3
$446K Buy
10,824
+16
+0.1% +$659 ﹤0.01% 3664
2018
Q2
$620K Buy
+10,808
New +$620K ﹤0.01% 3550